insights_auto
Kwa nini AMGN34 imeongezeka kwa 2.63%?
Fahamu zaidichevron_right
AMGN34:BVMF
Amgen Inc. BDR
R$ 73.64
arrow_upward
+2.63%(+1.89) Siku 1
7 Okt, 11:46:33 GMT -3 · BRL
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AMGN34...
Fungua
R$ 73.64
Juu
R$ 73.64
Chini
R$ 73.64
Mtaji wa soko
223.86B
Wastani wa kiasi cha mauzo
412.00
Kiasi cha mauzo ya hisa
35.00
Juu kwa wiki 52
R$ 83.06
Chini kwa wiki 52
R$ 47.76
Hisa za wawekezaji
540.63M
Idadi ya wafanyakazi
elfu 32
Fungua
R$ 73.64
Juu
R$ 73.64
Chini
R$ 73.64
Mtaji wa soko
223.86B
Wastani wa kiasi cha mauzo
412.00
Kiasi cha mauzo ya hisa
35.00
Juu kwa wiki 52
R$ 83.06
Chini kwa wiki 52
R$ 47.76
Hisa za wawekezaji
540.63M
Idadi ya wafanyakazi
elfu 32
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
MarketBeat
·
dakika 50 zilizopita
Morgan Stanley Has Lowered Expectations for Amgen (NASDAQ:AMGN) Stock Price
Investing.com
·
saa 1 iliyopita
Truist raises Amgen stock price target to $380 on pipeline growth
Yahoo Finance
·
saa 2 zilizopita
Amgen (AMGN) Backs $30 Million Series A Round In AI Genetic Testing
AD HOC NEWS
·
saa 2 zilizopita
Amgen announces Sjogren's trial results: Amgen stock gains 1.59 percent
Wasifu
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Kuhusu Amgen Inc. BDR
Afisa Mkuu Mtendaji (CEO)Robert A. Bradway
Wafanyakazielfu 31.5
Lilianzishwa1980
Makao makuuThousand Oaks, California, Marekani
Sekta-
Tovutiamgen.com